Lee S[au] - Search Results

Year	Number of Results
1876	1
1938	1
1943	2
1944	3
1945	1
1947	6
1948	4
1949	2
1950	1
1951	6
1952	3
1953	4
1954	5
1955	6
1956	6
1957	4
1958	12
1959	4
1960	13
1961	12
1962	47
1963	31
1964	19
1965	33
1966	27
1967	26
1968	33
1969	30
1970	45
1971	56
1972	58
1973	51
1974	52
1975	69
1976	91
1977	89
1978	84
1979	81
1980	107
1981	78
1982	112
1983	121
1984	111
1985	146
1986	202
1987	207
1988	277
1989	293
1990	313
1991	317
1992	361
1993	380
1994	472
1995	514
1996	608
1997	621
1998	691
1999	826
2000	1072
2001	1297
2002	1419
2003	1706
2004	2046
2005	2420
2006	2729
2007	3238
2008	3624
2009	4115
2010	4885
2011	5666
2012	6305
2013	6516
2014	6904
2015	7501
2016	7734
2017	7878
2018	8221
2019	8084
2020	9069
2021	9729
2022	6664
2023	3

1

Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer.

Choi YJ, Kim DS, Sung YH, Kim DH, Im K, Lee H, Lee CW, Cho J, Min J, Woo DC, Kim SE, Lee S, Kong YJ, Ryu HC, Kim JS, Rengasamy R, Ji W, Choi CM, Lee JC, Rho JK. Choi YJ, et al. Among authors: lee s. Cancer Res. 2022 Aug 26:OF1. doi: 10.1158/0008-5472.CAN-22-2507. Online ahead of print. Cancer Res. 2022. PMID: 36018295 No abstract available.

2

4D Cell-Condensate Bioprinting.

Ding A, Lee SJ, Tang R, Gasvoda KL, He F, Alsberg E. Ding A, et al. Among authors: lee sj. Small. 2022 Sep;18(36):e2202196. doi: 10.1002/smll.202202196. Epub 2022 Aug 16. Small. 2022. PMID: 35973946

3

Authors' response.

Watanabe K, Lee S, Lee D, Zheng F, Kyung HM, Kim DG, Deguchi T. Watanabe K, et al. Among authors: lee s. Am J Orthod Dentofacial Orthop. 2022 Sep;162(3):288-289. doi: 10.1016/j.ajodo.2022.05.013. Am J Orthod Dentofacial Orthop. 2022. PMID: 36049859 No abstract available.

4

Pharmaceutical security for Canada.

Lee SK, Mahl SK, Rowe BH, Lexchin J. Lee SK, et al. CMAJ. 2022 Aug 22;194(32):E1113-E1116. doi: 10.1503/cmaj.220324. CMAJ. 2022. PMID: 35995443 Free article. No abstract available.

5

Engineering Organ-on-a-Chip to Accelerate Translational Research.

Ko J, Park D, Lee S, Gumuscu B, Jeon NL. Ko J, et al. Among authors: lee s. Micromachines (Basel). 2022 Jul 28;13(8):1200. doi: 10.3390/mi13081200. Micromachines (Basel). 2022. PMID: 36014122 Free PMC article. Review.

6

Autophagy: Guardian of Skin Barrier.

Kim HJ, Park J, Kim SK, Park H, Kim JE, Lee S. Kim HJ, et al. Among authors: lee s. Biomedicines. 2022 Jul 28;10(8):1817. doi: 10.3390/biomedicines10081817. Biomedicines. 2022. PMID: 36009363 Free PMC article. Review.

7

Disease-associated oligodendrocyte responses across neurodegenerative diseases.

Pandey S, Shen K, Lee SH, Shen YA, Wang Y, Otero-García M, Kotova N, Vito ST, Laufer BI, Newton DF, Rezzonico MG, Hanson JE, Kaminker JS, Bohlen CJ, Yuen TJ, Friedman BA. Pandey S, et al. Among authors: lee sh. Cell Rep. 2022 Aug 23;40(8):111189. doi: 10.1016/j.celrep.2022.111189. Cell Rep. 2022. PMID: 36001972 Free article.

8

Cancer-associated vasculitides: a single-centre case series.

Do H, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Do H, et al. Among authors: lee sw. Clin Rheumatol. 2022 Sep 9. doi: 10.1007/s10067-022-06363-0. Online ahead of print. Clin Rheumatol. 2022. PMID: 36083400

9

Isolinderalactone inhibits glioblastoma cell supernatant-induced angiogenesis.

Lee SY, Park JH, Cho KH, Kim H, Shin HK. Lee SY, et al. Oncol Lett. 2022 Aug 2;24(4):328. doi: 10.3892/ol.2022.13448. eCollection 2022 Oct. Oncol Lett. 2022. PMID: 36039052 Free PMC article.

10

Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2.

Lee SJ, Kim YJ, Ahn DG. Lee SJ, et al. J Microbiol Biotechnol. 2022 Aug 23;32(9):1-10. doi: 10.4014/jmb.2206.06064. Online ahead of print. J Microbiol Biotechnol. 2022. PMID: 36039385 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results